BioNTech SE (BNTX) Gains from Investment Securities (2018 - 2025)
BioNTech SE (BNTX) posted Gains from Investment Securities of -$931234.8 for Q4 2025, up 38.73% on a QoQ basis from -$1.5 million in Q3 2025, and down 771.46% year-over-year from $138688.7 in Q4 2024.
BioNTech SE (BNTX) has 8 years of Gains from Investment Securities data on file, last reported at -$931234.8 in Q4 2025.
- In Q4 2025, Gains from Investment Securities fell 771.46% year-over-year to -$931234.8; the TTM figure through Dec 2025 stood at -$15.4 million (up 94.53% YoY), while the FY2025 annual figure was -$2.8 million, down 781.07% from the prior year.
- Gains from Investment Securities grew to -$931234.8 in Q4 2025, from -$1.5 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $4.8 million in Q4 2021 and bottomed at -$1.4 billion in Q1 2022.
- A 5-year average of -$318.5 million and a median of -$1.3 million in 2021 frame the typical range for Gains from Investment Securities.
- Annual changes were most pronounced in 2021 — Gains from Investment Securities soared 212094123.02% — and 2022, when it slumped 1200275504607.64%.
- Year by year, Gains from Investment Securities stood at $4.8 million in 2021, then slumped by 29560.69% to -$1.4 billion in 2022, then soared by 95.05% to -$70.0 million in 2023, then jumped by 99.85% to -$106859.5 in 2024, then tumbled by 771.46% to -$931234.8 in 2025.
- The last three Gains from Investment Securities figures came in at -$931234.8 (Q4 2025), -$1.5 million (Q3 2025), and -$12.8 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -931,234.81 |
| Dec 31, 2025 | -931,234.81 |
| Sep 30, 2025 | -1.52 Mn |
| Sep 30, 2025 | -1.52 Mn |
| Mar 31, 2025 | -12.83 Mn |
| Mar 31, 2025 | -12.83 Mn |
| Dec 31, 2024 | -106,859.54 |
| Dec 31, 2024 | -106,859.54 |
| Jun 30, 2024 | -215,377.52 |
| Jun 30, 2024 | -215,377.52 |
| Mar 31, 2024 | 24.23 Mn |
| Mar 31, 2024 | 24.23 Mn |
| Dec 31, 2023 | -70.04 Mn |
| Dec 31, 2023 | -70.04 Mn |
| Sep 30, 2023 | 3.59 Mn |
| Sep 30, 2023 | 3.59 Mn |
| Jun 30, 2023 | 108,892.44 |
| Jun 30, 2023 | 108,892.44 |
| Mar 31, 2023 | -906.87 Mn |
| Mar 31, 2023 | -906.87 Mn |
| Dec 31, 2022 | -1.42 Bn |
| Dec 31, 2022 | -1.42 Bn |
| Sep 30, 2022 | -759.53 Mn |
| Sep 30, 2022 | -759.53 Mn |
| Jun 30, 2022 | -844.47 Mn |
| Jun 30, 2022 | -844.47 Mn |
| Mar 31, 2022 | -1.45 Bn |
| Mar 31, 2022 | -1.45 Bn |
| Dec 31, 2021 | 4.80 Mn |
| Dec 31, 2021 | 4.80 Mn |
| Sep 30, 2021 | -1.18 Mn |
| Sep 30, 2021 | -1.18 Mn |
| Jun 30, 2021 | -240,854.29 |
| Jun 30, 2021 | -240,854.29 |
| Mar 31, 2021 | -0.12 |
| Mar 31, 2021 | -0.12 |
| Dec 31, 2020 | 2.27 |
| Dec 31, 2020 | 2.27 |
| Mar 31, 2020 | -220,787.81 |
| Mar 31, 2020 | -220,787.81 |
| Dec 31, 2019 | -522,450.98 |
| Dec 31, 2019 | -522,450.98 |
| Dec 31, 2018 | 327,564.79 |
| Dec 31, 2018 | 327,564.79 |